LSC Webinars CELL All

  1. The Future Of Cell Culture Media Development 8/18/2026

    Predictive modeling and AI are helping reshape cell culture media. Learn how these approaches can focus experimental efforts, accelerate learning, and support more efficient development decisions.

  2. From Data To Decisions: AI And Multi-Omics For Cell Culture Development 8/13/2026

    See how combining multi-omics data, AI-enabled analytics, and expertise can reveal the biological drivers of process performance, helping biologics developers identify optimization opportunities.

  3. IRB In Action: A Live Mock Board Review 8/12/2026

    Experience a live mock IRB review! Watch industry experts evaluate a fictional protocol to uncover insights into board decision-making, master the review process, and improve your future submissions.

  4. How Modular Workflows Are Redefining CAR T Manufacturing 7/30/2026

    Learn how flexible modular workflows can help manufacturers improve process adaptability, throughput, and control while preserving key CAR T quality attributes, including transduction efficiency.

  5. Rewriting The Code: Advances And Challenges In Pediatric Gene Therapy 7/28/2026

    This presentation examines pediatric gene therapy and the three platforms now driving clinical progress: AAV vectors, lentiviral vectors, and CRISPR-based gene editing.

  6. Navigating AI Compliance In Life Sciences: FDA Policy Insights For AI Governance 7/22/2026

    Navigating life sciences AI compliance requires strong governance, expert human oversight, and transparent, low-risk deployment strategies.

  7. When High-Stakes ADC Decisions Can't Wait for More Material or Better Data 7/21/2026

    Learn how a material-sparing analytical workflow can generate reliable data, reduce dependence on calibration assays, and support faster, more confident candidate evaluation.

  8. Reducing Particulate-Related Batch Risk In Bioprocessing 7/1/2026

    Increasing scrutiny around particulate contamination is pushing teams to act earlier. Understanding where risks originate and applying proactive strategies can ease challenges across production.

  9. A Closer Look At How Single Use Consumables Drive Cost Per Therapy 7/1/2026

    Single-use consumables can influence cost per therapy, validation risk, and scalability. Gain a practical perspective on spotting cost and risk signals early before they become barriers later.

  10. Residual DNA Testing Across Biotherapeutics 6/30/2026

    Residual host cell DNA testing can create bottlenecks. Learn how digital PCR supports more consistent quantification, simpler method deployment, and faster in-process and lot release decisions.